Back to today’s briefing

Story perspectives

Revolutionary A.I. Blood Test Promises Early Lyme Detection

7/29/2025

32 4

Summary

Story summary

A groundbreaking A.I.-powered blood test for Lyme disease, named LymeSeek, has been developed by researchers at ACES Diagnostics. With over 90% accuracy in early detection, this innovative test combines 10 protein antigens to significantly lower the risk of chronic illness. Set to hit the market by late 2026, it could revolutionize Lyme disease diagnosis and treatment across the U.S.

1 of 1

Story summary

A groundbreaking A.I.-powered blood test for Lyme disease, named LymeSeek, has been developed by researchers at ACES Diagnostics. With over 90% accuracy in early detection, this innovative test combines 10 protein antigens to significantly lower the risk of chronic illness. Set to hit the market by late 2026, it could revolutionize Lyme disease diagnosis and treatment across the U.S.